Purchase Order 75D30121P10377
Award Date 2/23/21
Potential Completion Date 8/22/21
Potential Value $133K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30332, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) Atlanta awarded a $145.8K firm fixed-price purchase order to Georgia Tech Research Corporation to characterize pathogen-specific antibody responses related to COVID-19. The award, issued on August 25, 2021, carries an ultimate completion date of August 31, 2025, with performance taking place in Atlanta, Georgia. No set-aside designation was applied to this contract, indicating open competition. Georgia Tech Research Corporation, operating...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order contract worth $133,000.00 to Georgia TECH Research Corporation, doing business as the Office of Sponsored Programs, for the development of monoclonal antibodies. This is a non-set-aside contract with a performance period ending on March 15, 2024. Georgia TECH Research Corporation, a non-profit research organization and state institution of higher education, has...
- <p>CDC Pittsburgh awarded a purchase order to the State of Georgia Department of Public Health for $69,309.00 on June 8, 2026, with an ultimate completion date of May 1, 2027. Performance takes place in Atlanta, Georgia. The order carries no small business set-aside. Pricing is firm fixed price. The specific scope of work is not detailed in the source material.</p>
- <p>The Centers for Disease Control and Prevention (CDC) Pittsburgh issued a purchase order to Georgia TECH Research Corp on September 6, 2023, for molecular dynamics modeling, valued at $94,061.00 under a firm fixed-price contract. Performance is located in Atlanta, Georgia, with an ultimate completion date of September 10, 2026. No set-aside was applied to this acquisition.</p>
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Georgia Tech Research Corporation (Georgia Tech) for the development of anti-pertussis antibodies. The contract has a ceiling value of $112,500.00 and a period of performance through August 28, 2023. Georgia Tech is a non-profit research organization and state institution of higher education associated with the Georgia Institute of Technology. The contract does not have a set-aside...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Georgia Tech Research Corporation (Georgia Tech) for $300,000.00 to provide mathematical modeling in support of the COVID-19 response. The contract period of performance is from May 10, 2021 to April 25, 2022. This award does not have a small business set-aside designation. Georgia Tech, a non-profit research organization and state institution of...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $599,899.12 definitive contract to the Georgia Tech Research Corporation (Georgia Tech) to support COVID-19 research under the FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 3.1. The contract, which does not have a set-aside designation, is for a project titled "FY 2020 COVID-19 BAA TOPIC 3.1 GA TECH" with a period of performance through September 29, 2022. As a non-profit research organization and state...
- This $400,185.00 definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation (Georgia Tech) to support COVID-19 research under the FY 2020 Broad Agency Announcement (BAA) Topic 1. The contract has a period of performance ending on June 30, 2022 and does not have a set-aside designation. As a non-profit research organization and state institution of higher learning, Georgia Tech has extensive experience conducting research and...
- The Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to University of Georgia Research Foundation, Inc., for $64,572.00 on September 30, 2026, to maintain access to the Advanced Photon Source SER-CAT beam lines for structural analysis of influenza viral proteins. Place of performance is Athens, Georgia. The procurement supports macromolecular crystallography and data collection, analysis, and interpretation using the contractor's specialized equipment and...
- <p>The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a purchase order to Emory University for $243,120 on September 1, 2024, for antiretroviral specimen study support. Work is performed in Atlanta, Georgia, with an ultimate completion date of August 31, 2026. The purchase order is firm fixed price with no small business set-aside.</p>
CDC Pittsburgh awarded a purchase order to Georgia TECH Research Corp for development of monoclonal antibodies and immunoassays to spike variants, with a ceiling value of $133,000, on February 23, 2021. Work is performed in Atlanta, Georgia, under firm fixed-price terms with an ultimate completion date of August 22, 2021. The effort supports the national interest action code for Coronavirus COVID-19 response.
Generated 6/13/26, 9:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 2/28/21 | |
| Not listed | Not listed | $133.0k | 2/22/21 |